| Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | 09/05 16:00 | globenewswire.com |
| Arcutis: Shares Plateau After Early 2024 Gains, But Further Upside Looks Likely | 08/22 17:13 | seekingalpha.com |
| Arcutis to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference | 08/22 08:00 | globenewswire.com |
| Arcutis Biotherapeutics, Inc. (ARQT) Q2 2024 Earnings Call Transcript | 08/15 00:43 | seekingalpha.com |
| CORRECTION – Arcutis Announces Second Quarter 2024 Financial Results and Provides Business Update | 08/14 21:00 | globenewswire.com |
| Arcutis Biotherapeutics, Inc. (ARQT) Reports Q2 Loss, Misses Revenue Estimates | 08/14 18:12 | zacks.com |
| Arcutis Announces Second Quarter 2024 Financial Results and Provides Business Update | 08/14 16:00 | globenewswire.com |
| Will Arcutis Biotherapeutics, Inc. (ARQT) Report Negative Earnings Next Week? What You Should Know | 08/07 11:06 | zacks.com |
| Arcutis Announces ZORYVE® U.S. Co-promote Agreement with Kowa Pharmaceuticals America, Inc. | 07/29 07:35 | globenewswire.com |